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Abstract
Cognitive defects in autism spectrumdisorder (ASD) include socialization and communica-
tion: key behavioral capacities that separate humans from other species. Here, we analyze
gene expression in the prefrontal cortex of 63 autism patients and control individuals, as
well as 62 chimpanzees and macaques, from natal to adult age. We show that among all
aberrant expression changes seen in ASD brains, a single aberrant expression pattern
overrepresented in genes involved synaptic-related pathways is enriched in nucleotide vari-
ants linked to autism. Furthermore,only this pattern contains an excess of developmental
expression features unique to humans, thus resulting in the disruption of human-specific
developmental programs in autism. Several members of the early growth response (EGR)
transcription factor family can be implicated in regulation of this aberrant developmental
change. Our study draws a connection between the genetic risk architecture of autism and
molecular features of cortical development unique to humans.
Author Summary
Autism spectrumdisorder (ASD) involves disruptions in cognitive functions related to
socialization and communication, which are also among the key behavioral capacities that
separate humans from other species. This suggests that ASD may involve alterations in
evolutionarily novel, human-specific developmental processes. To test this, we measured
developmental gene expression trajectories in the cerebral cortex of autism cases, matched
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controls, and non-human primates: chimpanzees and macaques. Among a large number
of disrupted developmental patterns that we detected in autism, only one, mainly includ-
ing synaptic genes, was enriched in autism-linked mutations. This suggests that changes in
expression of these genes in ASD brains may play a causal role in disease etiology. The
same gene set exhibited more developmental expression changes unique to the human
brain than any other developmental pattern disrupted in autism, reflecting extension of
the synaptic maturation period in humans. Taken together, we show that a recently
evolved developmental expression pattern of synaptic genes altered in autism might be
associated with intense social learning abilities unique to humans.
Introduction
Autism spectrumdisorder (ASD) is a common neurodevelopmental condition characterized
by the disruption of cognitive functions involved in socialization and communication and
inclination toward restricted interests and repetitive behaviors [1–4]. The global median preva-
lence of ASD is estimated at around 0.6% [5], though three to four times higher estimates have
also been reported [6,7].
In infants and children, autism can manifest itself within the first 2 y of age as delays or defi-
cits in joint attention, imitation, and communication [4]. Adult ASD individuals can have diffi-
culties in understanding the emotions of others, show low social interaction, display repetitive
motor movements, and display different levels of executive dysfunction [4,8]. ASD frequently
co-occurswith other neurodevelopmental abnormalities, including language and motor defi-
ciencies [4]. Based on the affected behaviors, a number of central nervous system structures
have been implicated to be altered in autism, including the frontal and temporal cortices and
the amygdala [4,9].
Imaging studies have shown multiple deviations from average brain development in the
brains of ASD individuals. These include increased deficiency in long-range connectivity and
low activity in integrative regions [10], which could underlie extremely focused interests in
ASD individuals [4]. Another theme is early postnatal brain overgrowth, including excess corti-
cal white and gray matter volumes, that can lead to “megacephalic”-like brain volumes at 2–3 y
in boys diagnosedwith ASD, which disappear with age due to subsequent brain undergrowth
[11]. A similar early overgrowth and later undergrowth pattern was reported for the amygdala
[12]. Another observation is aberrant development of white matter fiber tracts in the ASD neo-
cortex, with early acceleration and subsequent deceleration [13]. Stereological work reported
>60% higher neuron numbers in ASD children compared to unaffected children [14]. Studies
of synapse numbers have also reported an excess of synapse densities; specifically, greater den-
dritic spine densities were reported for the temporal cortex in ASD brains during postnatal
development [15], and in both frontal and temporal cortices in adulthood [16]. The excess of
spines in postnatal development appears to increase toward adolescence and has been corre-
lated with reduced developmental spine pruning as a result of high mTOR activity and
impaired autophagy [15].
Twin and family studies suggest that cognitive changes observed in autism are more than
50% heritable [17,18]. However, autism has been found to be genetically highly heterogeneous
[19,20]. A large number of genetic markers, including segregating and de novo mutations in
coding and regulatory regions, copy number variations, and chromosomal mutations, have
been linked to ASD by a sum of genetic linkage and genome-wide association studies, while
each of the identified genetic variants explains only a minute fraction of disease prevalence, no
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larger than 1% [4,19,21]. Genes associated with autism in these genetic scans are enriched in
two major biological processes: synaptic processes and transcription/chromatin modification
[9,21,22]. Some variants are notable for association with other neurodevelopmental conditions,
such as schizophrenia, epilepsy, and intellectual disability [21] (which can be concurrent with
autism [4]). Interestingly, genes carrying de novo ASD risk mutations were reported to show
peak expression in fetal cortical development and in cortical projection neurons in the unaf-
fected brain [23,24]; such genes’ altered activity may thus contribute to abnormal connectivity
patterns observed in ASD. Meanwhile, genes carrying segregating (i.e., relatively common)
ASD risk alleles were reported to be highly expressed in early postnatal development and have
roles in synaptic functions [24], consistent with atypical synaptogenesis in ASD [16].
In addition to genetic analyses, transcriptome comparisons of postmortemneocortex tissue
from individuals diagnosedwith ASD and from unaffected individuals have revealed a number
of phenomena. First, there is massive and consistent downregulation of genes predominantly
involved in synaptic functions (despite the spine density excess reported in histological work
[15,16]) [25–28]. Second, there is strong upregulation of immune and inflammation-related
response genes. Third, synaptic genes, but not immune genes, overlap with putatively causal
markers identified in genetic linkage or association studies, indicating that immune upregula-
tion and microglial activation occur downstream of earlier developmental aberrations [25,28]
(although immune upregulation and inflammation could also explain important phenomena,
such as neuron overgrowth in the ASD brain [28]). Fourth, genes involved in cortical pattern-
ing appear dysregulated [25,27], such that expression differences between temporal and frontal
cerebral cortices observed in unaffected brains were obscured in ASD brains [25].
One limitation of these transcriptome studies has been their focus on fixed gene expression
differences across all ages. Given the transient nature of multiple ASD-related phenotypes [11–
14], studying molecular differences between unaffected and ASD brains across postnatal brain
development could provide additional insight into ASD etiology. A second limitation pertains
to linking the observedmolecular changes with the two major behavioral characteristics of
ASD-impaired social interaction and restricted behavior. Animal models can help overcome
this hindrance [15,29], but here we propose an alternative approach, leveraging upon the
notion that the cognitive functions disrupted in autism are among the key behavioral capacities
that separate humans from other species [30]. Indeed, the niche that has allowed ratchet-like
cultural accumulation in the human lineage was founded upon the evolution of a powerful set
of social skills, including theory of mind, imitation, empathy, and cooperation [31–35]. This
suggests that some ASD phenotypes may represent disruption of evolutionarily novel, human-
specific developmental processes. Accordingly, developmental shift in expression of synaptic
genes in the frontal cortex has been shown to be one of the most prominent human-specific
changes in postnatal brain development [36,37].
In this study, we investigate the developmental mechanisms underlying ASD, employing tran-
scriptome-wide analysis of expression variation throughout postnatal cortical development, start-
ing from the earliest ages at which autism can be diagnosed.We report a group of co-expressed
genes involved in synaptic function and development, which show divergent expression between
ASD and unaffected brains from childhoodonward. We further show this gene set’s connection
to evolutionarily novel developmental features characteristic of the human neocortex.
Results
Gene Expression in Autistic and Control PFC Development
To determine the developmental dynamics of gene expression changes in autism, we measured
transcript levels in the prefrontal cortex (PFC) of 34 autism cases (2–60 y old) and 40 controls
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(0–62 y old) using RNA sequencing (RNA-seq; Fig 1A and S1 Table). Based on more than 700
million sequence reads, we quantified the expression of 12,557 protein-coding genes in 63 indi-
viduals (S1 and S2 Tables and S1 Data). The age of the individuals explained 23.8%, and autism
diagnosis 6.6%, of the of the total expression variation. By contrast, other factors, such as gen-
der and RNA quality and sample preparation batch as confounds, collectively explained 4.1%
(Fig 1B).
A total of 1,775 genes were differently expressed between autism cases and unaffected con-
trols in our data (ANCOVA, p< 0.01, permutation-based false discovery rate (FDR) = 0.078).
These genes overlapped significantly with expression differences determined using an alterna-
tive statistical procedure, the likelihood ratio test implemented in the DESeq2 package [30], set
to the same FDR level (Fisher's exact test, p< 0.0001, odds ratio = 38.7), as well as differentially
expressed genes reported in the autistic frontal cortex via microarray-based study [25] (Fisher's
exact test, p< 0.0001, odds ratio = 2.46) and with genes identified by reanalysis of published
microarray data [25,36] (Fisher’s exact test, p< 0.0001, odds ratio = 1.54). Furthermore, the
direction of expression change in autism determined in our study was concordant with results
obtained using microarrays [25,36], even though 50 of the 63 individuals did not overlap
between studies (Pearson correlation, r = 0.68, p< 0.0001; S1 Fig).
Unsupervised clustering of the 1,775 genes resulted in six major patterns of developmental
expression profiles separating autism and control groups (Fig 2A and 2B; S2 Fig). In agreement
with previous observations [25–27], transcripts upregulated in autism (cluster 4) were prefer-
entially involved in immune functions, while transcripts downregulated in autism (cluster 2)
were involved in neural functions, including calcium signaling and long-term potentiation
pathways, as well as Gene Ontology (GO) terms associated with synaptic transmission and
cell–cell signaling (one-sided hypergeometric test, corrected p< 0.05; Fig 2C and S3 Table). In
addition to these previously reported functions, we found expression changes enriched in cellu-
lar metabolic and biosynthetic processes (cluster 1), generation of precursor metabolites and
energy and catabolic process (cluster 3), regulation of transcription (cluster 5), and regulation
of cellular process (cluster 6). Clustering based on log2-transformed expression values (S3 and
S4 Figs), as well as expression values of all detected genes, demonstrated robustness of
Fig 1. Gene expression in PFC development in autismand control groups. (A) Transcriptional similarity among autism and control cases duringPFC
development, visualized using multidimensional scaling (MDS)with expression correlation as distance (S2 Data). Each circle represents an individual.
The size of the circles is proportional to the individuals’ age (smaller circles correspond to younger individuals). The border colors represent different
groups (black: autism cases, red: controls). The filled colors with different shades indicate the levels of cognitive decline for autistic individuals (darker
purple correspond to more severe cases). The first dimension correlateswith levels of cognitive decline (Pearson correlation, r = 0.42, p < 0.001) and the
second with age (Pearson correlation, r = 0.73, p < 0.001). (B) Proportions of the total expression variation explained by disease status, age, sex, RNA
quality, and sample batch across all 12,557 genes expressed in autism and control cases. (C) Distance between the expression trajectoryof control
group and autism cases with different levels of Autism Diagnostic Interview-Revised (ADI-R) scores. Darker shade of purple corresponds to higher ADI-R
scores.
doi:10.1371/journal.pbio.1002558.g001
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clustering results, especially for cluster 2 genes (S5 and S6 Figs). Cluster 2 genes also overlapped
significantly with genes reported by other studies of transcriptome changes in autism [25,28]
(Fisher's exact test, p = 0.0043 and odds ratio = 1.68 for genes in [28]; p = 0.0004 and odds
ratio = 2.89 for genes in [25]). Notably, the extent of the expression difference between autism
and control cases positively correlated with the Autism Diagnostic Interview-Revised(ADI-R)
scores (Pearson correlation, r> 0.5, p< 0.05; Fig 1C and S4 Table). Patterns of age-related
expression divergence were not, however, driven by these extreme cases, as re-plotting clusters
based only on autism samples with moderate ADI-R scores confirmed all cluster profiles
(S7 Fig).
Frequency of Autism-AssociatedGenetic Variants in Gene Expression
Clusters
To test whether any of the detected expression changes might be linked with the cause of dis-
ease, we assessed the occurrence of genes with DNA sequence polymorphisms and mutations
associated with ASD in each of the six clusters. Notably, genes in cluster 2, but not in the other
five clusters, contained a significant excess of genes with genetic variants associated with ASD,
based on analysis of all genes extracted from SFARI AutDB (791 genes) [38], category 1–4
genes from SFARI AutDB (375 genes), genes from AutismKB database (977 genes) [39], as
well as genes with de novo mutations associated with autism collected from four exome
sequencing studies (permutation test, p< 0.05 for all tests; Fig 2D and S8 Fig) [8,10–12]. This
result was not affected by gene length differences between clusters (S9 and S10 Figs). This sug-
gests that disruption of the synaptic gene developmental expression pattern, represented by
cluster 2, may represent one of the primary causes of ASD, while other expression changes rep-
resent its consequence.
Fig 2. Developmental dynamics of gene expression changes in autisticbrains. (A) Hierarchical clusteringof 1,775 genes differently expressed
between autism cases and unaffected controls (S3 Data). (B) Expression patternsof the six major gene clusters. The x-axis shows the age information
on the (age)1/4 scale; the y-axis shows the expression levels standardized to mean = 0 and standard deviation = 1 before plotting. The points represent
mean expression levels in each individual (red: controls; black: autism cases); the lines show cubic spline curves fitted to the individual data; the shaded
areas show the standard deviation of the spline curves within a cluster. The cluster number and the number of genes within the cluster are shown on top
of the panels. (C) Summaryof functional pathways enriched in each cluster (S3 Table). (D) Overlap between genes with 1–4 scores in SFARI AutDB
linked to autism by genetic association studies and six major clusters of expression changes in autism (S4 Data). The red bars show the numbers of
overlapping genes; the streaked bars show themean numbers of overlapping genes expected by chance, estimated by 1,000 permutations of cluster
labels. The symbols above the bars show the significance based on 1,000 permutations of cluster labels (**: p < 0.01).
doi:10.1371/journal.pbio.1002558.g002
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Localization of Genes Affected in Autism in Cell Types and Cortical
Layers
To further investigate the functional roles of genes showing significant expression changes in
autistic brains, we assessed the distribution of genes in each of the six clusters among brain cell
types and cortical layers. Based on mouse brain cell type makers reported in [16], we found
that cluster 2 were significantly over-represented among genes highly expressed in three types
of neurons assessed in [16], CA1 pyramidal cells, interneurons, and S1 pyramidal cells, but not
in non-neuronal cells. Cluster 5 genes were over-represented among S1 pyramidal cell markers,
and cluster 3 genes tended to overlap with interneuron markers (S11 Fig). These observations
were generally consistent with results based on mouse neuronal marker genes reported in [40]
(S12 Fig).
Given enrichment of cluster 2, 3, and 5 genes in neuronal markers, as well as enrichment of
cluster 2 genes in GO terms “synaptic transmission” and “cell–cell signaling,” we further col-
lected genes annotated to be predominantly localized in the presynapse, postsynapse, synaptic
vesicle, axon, dendrite, and remaining neuron locations based on GO. Genes in cluster 2 were
significantly over-represented among genes located in synaptic vesicles and dendrites, but not
in other neuron locations (S13 Fig). By contrast, genes in the other clusters showed no signifi-
cant over-representation in any of the subcellular structures of neurons. Taken together, these
observations further support the notion that cluster 2 genes are linked to synaptic transmission
and neuronal signaling.
Using marker genes of cortical layers 2–6 identified in rhesus macaque brains [14], we fur-
ther found that genes in cluster 4 show significant over-representation among cortical layer 5
markers (S14 Fig). This observation agrees with the notion implicating genes expressed in deep
cortical layers during mid-fetal embryonic development as pertinent to ASD [35]. Intriguingly,
genes in clusters 2 and, to a lesser extent, cluster 3 were significantly over-represented among
cortical layer 2 markers, which is also in line with observations of gene expression dysregula-
tion in adult ASD patients in cortical layers 2/3 (S14 Fig) [24].
Comparisonof Autistic and Human-SpecificDevelopmental Expression
Profiles
ASD affects cognitive functions involved in socialization and communication [1–3], functions
that have also been suggested to underlie main aspects of human cognitive uniqueness relative
to other primates [30–33]. To test whether genes whose ontogenetic expression patterns are
changed in autism display human-specific properties, we measured gene expression levels in
the PFC of 39 chimpanzees (0–43 y old) and 36 rhesus monkeys (0–21 y old), using the same
RNA-seq procedure as for the human samples (Fig 3A, S1 and S2 Tables). Of the 12,557 genes
detected in the 38 human, 31 chimpanzee, and 31 macaque samples with good RNA quality
(S1 Table), 1,070 (8.5%) showed developmental expression profiles specific to humans
(ANCOVA test, p< 0.01, permutation-based FDR< 0.01). The expression of these genes
across PFC development correlated well with published human, chimpanzee, and rhesus mon-
key data measured using microarrays (mean r = 0.7, p< 0.0001; S15 Fig) [36,37]. Furthermore,
in agreement with previous observations [36,37], the proportion of developmental gene expres-
sion profiles specific to humans exceeded the proportion of chimpanzee-specific profiles by
approximately three-fold (Fig 3B).
Remarkably, among six clusters of genes differentially expressed between autism and control
groups, only cluster 2 contained a substantial and significant excess of genes showing human-
specific expression profiles during PFC development detected in either RNA-seq or microarray
datasets (permutation test, p< 0.001; Fig 3C), with 82% of them converging on the same
Disruptionof an Evolutionarily Novel Synaptic Expression Pattern in Autism
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common human-specific developmental expression pattern in both datasets (Fig 3D). Among
these genes, the functional categories synaptic transmission, calcium signaling pathways, cell
communication, as well as 14 other pathways associated with synaptic functions are highly over-
represented (one-sided hypergeometric test, corrected p< 0.05; S5 Table). Although based on a
Fig 3. Relationship betweenhuman-specific and autism-related developmental changes. (A) A global view of
transcriptional similarity among autism and control cases, as well as chimpanzees andmacaques, visualized usingMDS
with expression correlation as distance. Each circle represents an individual. The size of the circles is proportional to the
individuals’ age (smaller circles correspond to younger individuals). The colors represent different species (black: autism
cases; red: controls; blue: chimpanzees; green: macaques). The first dimension correlateswith hominid–monkey
divergence (Pearson correlation, r = 0.80, p < 0.001) and the second with age (Pearson correlation, r = 0.81, p < 0.001). (B)
Numbers of genes showing age-related and species-specific developmental profiles (red: human controls; blue:
chimpanzees). (C) Overlap between genes showing human-specific developmental profiles and six major clusters of
expression changes in autism (S4 Data). The red bars show the numbers of overlapping genes; the streaked bars show the
mean numbers of overlapping genes expected by chance, estimatedby 1,000 permutations of cluster labels. The symbols
above the bars show the significance of the overlap based on 1,000 permutations (***: p < 0.001). (D) Expression profiles
of genes showing human-specific developmental profiles and expression divergence between autism and control cases in
cluster 2 measured by RNA-seq (left panel) or microarrays (right panel). The x-axis shows the age information on the (age)1/
4 scale; the y-axis shows the expression levels standardized to mean = 0 and standard deviation = 1 before plotting. The
points represent mean expression levels in each individual (red: controls; black: autism cases; blue: chimpanzees; green:
macaques), the lines show cubic spline curves fitted to the individual data, and the error bars show standard deviation of the
spline curves. The numbers of genes used for plotting are shown on top of the panels.
doi:10.1371/journal.pbio.1002558.g003
Disruptionof an Evolutionarily Novel Synaptic Expression Pattern in Autism
PLOS Biology | DOI:10.1371/journal.pbio.1002558 September 29, 2016 7 / 23
small number of samples spanning the critical age interval, previous results [36,41–43], as well as
the current data, indicate that peak expression of synaptic genes is substantially delayed and
extended in human PFC development compared to both chimpanzees and macaques: from 0–2
years in non-human primates to 4–10 years in humans (Fig 2D and S16 Fig). In the autistic
brain, expression of synaptic genes starts decreasing from the earliest measured time point, 2
years of age, much earlier than in the control individuals (Fig 2D). This might imply that the tim-
ing of expression of synaptic genes in PFC is accelerated in autism, which resonates with prema-
ture PFC development described for ASD [11,44]. Furthermore, the average profile of all
synapse-related genes follows the expression trajectory closely resembling the trajectory of cluster
2 genes with human-specific expression (S17 Fig). This observation further implies an acceler-
ated dynamic of synaptic maturation during the first years of postnatal development in autism,
suggesting a potential mechanism for the resulting disruption of cognitive functions.
Regulation of Aberrant Expression of Synaptic Genes in Autism
To assess which regulatorymechanisms might drive the aberrant expression of cluster 2 genes
in autism, we first examined reported changes in the density of trimethylated histone H3K4
(H3K4me3, an epigeneticmark that on a genome-wide scale broadly correlates with active pro-
moters) in neurons isolated from PFC of autism and control cases of different ages [45]. We
found a significant excess of positive correlations between gene expression and H3K4me3 den-
sity changes in autism for genes in clusters 3 and 5 (one-sidedWilcoxon test, p< 0.05; S18
Fig). Notably, clusters 3 and 5 contain genes preferentially expressed in neurons (S11 and S12
Figs). Thus, H3K4me3 density changes might be associated with gene expression dysregulation
in neuronal cells in the autistic brain and are not specific to the aberrant regulation of synaptic
maturation.
We next tested the roles of transcription factors (TFs) in the regulation of expression
changes found in autism using target site predictions from Transfac [46]. Interestingly, we
found a significant enrichment of binding sites for 18 TFs in the promoters of cluster 2 genes,
but not genes in the other five clusters (permutation test, p< 0.01 for TFs; Fig 4A). Further-
more, among TFs showing significant binding site enrichment in cluster 2 genes, the expres-
sion patterns of four of these, early growth response proteins 1–4 (EGR1–4), were correlated
with the expression of their predicted targets (BH correctedMann-Whitney U [MWU] test,
p< 0.05; Fig 4A). The authenticity of the EGR target predictions used in this analysis was fur-
ther confirmed using data from chromatin immunoprecipitation followed by sequencing
(ChIP-seq) experiments conducted using EGR1 and EGR2 antibodies by the ENCODE project
[22] and by other studies [9,16] collected in a total of seven cell lines (S6 Table and S19 Fig).
The four TFs are early growth response proteins (EGR1–4), shown to be involved in the reg-
ulation of neuronal function, including synaptic activity [47], neuronal plasticity [48], and neu-
ronal cell death (Fig 4B and 4C) [49]. Strikingly, three of the four EGRs (EGR1-3) have been
previously identified as potential regulators of the human-specific delay in the timing of corti-
cal synaptogenesis [36], while less than one would be expected by chance (permutation test,
p< 0.001). Furthermore, genomic regions surrounding EGR1 display an excess of genetic
mutations linked to ASD (permutation test, p< 0.05 for EGR1; S20 Fig) [50]. Together, these
observations support the conclusion that EGRs have a role in the aberrant regulation of synap-
tic maturation in autism.
Discussion
Though multiple studies have considered aberrant gene expression changes in ASD, associating
these with behavioral phenotypes has continued to be a challenge. The evidence to date has
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pointed towards a causal role for down-regulation of synapse-related genes [25–27]. Our
results, based on time-series analysis of postnatal brain development in ASD, provide further
insight into this observation. First, among all expression changes detected in autism, we find
that only one major cluster is functionally linked to cognition-related physiological processes:
cluster 2 genes, but not genes in the other clusters, show significant localization preference
Fig 4. Potential regulators of gene expression changes in autism. (A) The numbers of TFs with significant binding site enrichment in
genes’ promoter regions in the six major clusters of expression changes in autism (left; S4 Data). The numbers of TFs showing binding site
enrichment,as well as significant positive correlation with expression profiles of its predicted target genes, within a cluster (right; S4 Data
and S5 Data). The gray bars show the observedTF numbers, and the streaked bars show themean number of TFs expected by chance,
estimated by 1,000 permutations of cluster labels. The symbols above the bars show the significance based on 1,000 permutationsof
cluster labels (**: p < 0.001; *: p < 0.1). (B) Predicted regulatorynetwork driving expression changes in autism represented by cluster 2
profile. The large circles represent regulatoryTFs (orange). The darker shade of colors represents regulators associated with human-
specific extension of cortical synaptogenesis [36,37]. The smaller circles represent cluster 2 targets of displayed TFs showing evolutionary
conserved (gray) and human-specific expression (red) duringPFC development. The purple lines indicate predictedTF-target gene
interactions (dark purple: correlation coefficientmore than 0.6; purple: correlation coefficient less than 0.6 but more than 0.3; light purple:
correlation coefficient less than 0.3), and the gray lines indicate protein–protein interactions collected from iRefindex database [6]. (C)
Expression profile of the EGR1-4. In each panel, points indicate individuals (red: controls; black: autism cases; blue: chimpanzees; green:
macaques); lines show cubic spline curves.
doi:10.1371/journal.pbio.1002558.g004
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towards synaptic vesicles and dendrites of neurons and are significantly enriched among genes
annotated to be involved in synaptic transmission (Fig 2C). Second, we demonstrate that genes
in cluster 2, albeit representing less than a quarter of genes with expression changes in autism,
are enriched in genetic mutations linked to the disease (Fig 2D). Third, our data shows that
down-regulation of synaptic genes in autism is already present by early childhood and likely
arises from altered synaptic development dynamics at earlier postnatal phases in ASD (Figs 2B
and 3D).
Thus, even though autism clearly involves a highly heterogeneous set of etiologies and
genetic conditions, aberrant developmental expression of synaptic genes might represent one
of its causes. This notion largely concurs with observations of greater neuron numbers, pruning
deficits, and rapid brain growth in children diagnosedwith ASD [14–16,51–53] and has the
potential to provide a mechanistic basis for the short-range synaptic hyper-connectivity and
long-range hypo-connectivity characteristic of the neocortex observed in ASD individuals
[10,54–57]. How atypical synaptic gene expression influences these diverse characteristics, how
much atypical expression is influenced by atypical environmental input, and whether synapto-
genesis in different brain regions are similarly affected, remain to be resolved.
Fourth, we find indication that the EGR family of zinc-finger transcription factors functions
as regulators of atypical synaptic expression in ASD, identified in cluster 2. A number of obser-
vations support the role of EGRs in ASD etiology: (a) as reported earlier, EGR1 displays an
excess of de novo mutations (S20 Fig) [50]; (b) variants disrupting EGR binding sites in the
Contactin-associatedprotein-like 2 (CNTNAP2) promoter were reported as risk factors for
ASD [58]; (c) MECP2, in which mutations cause Rett syndrome [29,59], was found to be regu-
lated by EGR2 in a positive feedback loop [60]; (d) compared to controls, EGR2 expression is
significantly lower in Rett syndrome and ASD brain samples [60], as well as in ASD lympho-
blastoid cells [61]. Multiple studies indicate the role of EGR family TFs in learning and synaptic
function [47,62], and recent work showed that EGR1 directly regulates GABA receptor sub-
units in the hippocampus [63]. It is therefore tempting to propose that the excitatory-inhibi-
tory imbalance, suggested to underlie ASD, could be directly EGR-driven.
Finally, our measurements taken at different points of cortical development allow us to
compare the transcriptome dynamics of brain development in ASD with evolutionary differ-
ences between humans and other primates. Comparative psychology has made two distinct
observations regarding ASD cognition and human evolution: (a) impaired social cognition,
which could be evolutionarily deleterious in hominin societies [30], and (b) hyper-systemizing
and attention to detail, a skill that could be beneficial and therefore positively selected [64]. In
our data, the dynamics of synaptic expression changes seen in autism in the PFC represent a
disruption of one of the most prominent human-specific developmental changes detected in
neurotypical brains: delayed expression of synaptic genes and extended period of synaptic mat-
uration [36], a trait thought to be critical for human social and linguistic learning [44]. This
observationmight explain the impairment of cognitive aspects suggested to be uniquely
human [30] in ASD.
Materials andMethods
Sample Collection
The study was reviewed and approved by the Institutional Animal Care and Use ethics com-
mittee at the Shanghai Institute for Biological Sciences, CAS. Informed consent for use of
human tissues for research was obtained in writing from all donors or their next of kin. All
non-human primates used in this study suffered sudden deaths for reasons other than their
participation in this study and without any relation to the tissue used. We used prefrontal
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cortex (PFC) samples from postmortem brains of 40 cognitively unaffected human controls
(0–62 years old), 34 autism cases (2–60 years old), 39 chimpanzees (0–43 years old), and 36
rhesus monkeys (0–21 years old) (S1 Table). Unaffected human samples were obtained from
the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Mary-
land, USA, and the Maryland Brain CollectionCenter, Maryland, USA. Autism samples were
obtained from NICHD Brain and Tissue Bank for Developmental Disorders and the Harvard
Brain Tissue Resource Center. Chimpanzee samples were obtained from the National Chim-
panzee Brain Resource (NS092988), the Alamogordo Primate Facility, New Mexico, USA, the
Anthropological Institute and Museum of the University of Zürich-Irchel, Switzerland, and the
Biomedical Primate Research Centre, the Netherlands. Rhesus monkey samples were obtained
from the Suzhou Experimental Animal Center, China. PFC dissections were made from the
frontal part of the superior frontal gyrus and all samples contained an approximately 2:1 grey
matter to white matter volume ratio.
RNA Sequencing (RNA-seq)
Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, California). Sequencing
libraries were prepared with TruSeq RNA Sample Preparation Kit (Illumina) according to
manufacturer’s instruction. Briefly, poly-T oligo-attached magnetic beads were used to isolate
long polyadenylated RNA from 1 μg of total RNA. After fragmentation, first-strand cDNA was
reverse transcribedwith random hexamer-primers, followed by second-strand cDNA synthe-
sis, end repair, adenylation of 30 ends, and ligation of the adapters. Fragments were then
enriched by PCR and sequenced on the Illumina Hi-seq 2000 system in seven lanes of one flow
cell, using the 100-bp single-end sequencing protocol. All samples were randomized prior to
library preparation and RNA sequencing.
RNA-seq Data Processing
In total, we obtained 1,495,421,886 RNA-seq reads, with an average sample coverage of
approximately 10 million reads (S2 Table). The procedures for data processing were previously
described [36]. Briefly, the raw sequencing reads were mapped to each specie’s reference
genome (hg19, panTro3, and rheMac2) and the splice junctions using Bowtie [65]. The splice
junction annotation was constructed using UCSC LiftOver tool (http://www.genome.ucsc.edu/
cgi-bin/hgLiftOver)by combining annotated conserved exons within a gene. Allowing up to
three mismatches, 86% of the reads could be mapped to the corresponding genome, 92% of
them uniquely (S2 Table). Only uniquely mapped reads were used in the downstream analysis.
Human gene annotation was downloaded from Ensembl (v66; http://www.ensembl.org).
Chimpanzee and rhesus monkey gene annotations were constructed from human gene annota-
tion using the LiftOver tool. Gene annotations were filtered to exclude transcripts with large
size differences among the three species; the difference in transcript length between species
should be smaller than the length of the shortest transcript. Gene expression levels of tran-
scripts were measured as RPKM values (reads per kilobase per million; S1 Data). If a gene con-
tained multiple transcripts, the expression level of the longest transcript was chosen. The
expression levels were standardized to mean = 0 and standard deviation = 1 before plotting. It
should be noted that the expression profiles of autism and control samples were normalized
together.
Identifying the Differentially ExpressedGenes in Autism
We identified differential expression between autistic samples and unaffected controls using
analysis of covariance (ANCOVA) [66] as described in [36,37,67,68]. The detailed description
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of the test applied is provided in the S1 Text. Briefly, for each gene, we chose the best polyno-
mial regression model with age as predictor and RPKM values as response, using a family of
polynomial regression models and the “adjusted r2” criterion. ANCOVA was then used to test
whether the regression model with disease-status parameters was significantly better than the
model with common parameters for both disease and control groups. The F-test was used to
compare the null model (with no disease-status parameters) with the alternative model (with
disease-status parameters). The permutations were performed by dividing samples into eight
age intervals and permuting disease-status identifiers within each interval in order to preserve
the age structure of the data. The FDR was calculated by 1,000 random permutations of sample
labels. One thousand, seven hundred seventy-five genes under F-test p< 0.01 and FDR = 0.078
were selected as differentially expressed genes in autism.
To test the robustness of the differential expression in autism calculated by ANCOVA, the
likelihood ratio test in the nbinomLRT function in R package “DESeq2” [30], with counts of
reads per gene as inputs, was used to test the significance of changes in deviance between a full
mode (~ age + group) and reduced mode (~age), where age is in days and group is the disease
status. P-values in the likelihood ratio test were adjusted by Benjamini-Hochberg (BH) adjust-
ment. One thousand, seven hundred thirty-two genes were identifiedwith adjusted p-values
less than 0.078, under the same cutoff in ANCOVA analysis.
To further evaluate the differential expression in autism, we estimated its overlap with the
differentially expressed genes in autistic brains reported previously [25], as well as the differen-
tially expressed genes, by reanalyzing the published microarray data by ANCOVA, in which
we re-normalized the expression profiles from a primates microarray dataset and an autism
microarray dataset measured in two different studies (S1 Text; there were 1,274 genes under
F-test p< 0.01) [25,36].
Clusteringof Autism-Related Expression Changes
Genes sharing expression pattern difference in autism were identified using hierarchical clus-
tering with (1-r), where r is the Pearson correlation coefficient, as the distance measure. The
correlations were calculated based on expression profiles of control and autistic samples. We
used the “complete” method of hierarchical clustering and cut the tree at a height from 2 to 0.3
(Fig 2A; S2 Fig). We discarded groups containing fewer than 40 genes. For each observedgene
group under each height cutoff, the KEGG and GO functional enriched terms were calculated
(S1 Text). The height cutoff = 1.4 yielded the highest enrichment of genes within clusters in
functional GO terms and KEGG pathways (S2 Fig; S3 Data). To evaluate the robustness of
autism-related expression patterns determined by the abovementioned procedure, we used the
log2-transformation of RPKM values as gene expression level measurement or determined
gene clusters based on all detected genes. These procedures resulted in 7 and 48 gene clusters,
respectively, under the uniform tree height cutoff of 1.4 (S3 and S4 Figs). The clustering pattern
enriched in synaptic genes, defined in our main analysis as cluster 2, remained robust using all
described clustering procedures (S5 and S6 Figs).
IdentifyingGenes with Species-Specific Expression
Genes with species-specificexpression were identified as described in previous studies [36,37].
Briefly, the differential expression test, described in [67], was performed on each species pair
twice, using either species as a reference. For each gene, if either of the two tests was significant
at a defined cutoff, we considered this gene as differentially expressed between the two species.
If a gene showed no significant expression differences between chimpanzees and macaques,
but showed significant differences between humans and the other two primate species, this
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gene was assigned to the human-specific gene set. Chimpanzee-specificgenes were defined
using the analogous criteria. The FDR of the differential expression test was estimated as previ-
ously described [36]. Briefly, samples were divided into six age intervals, and the species’ identi-
fiers were permuted within each group to preserve the age structure of the data. FDR was
calculated by 1,000 random permutations of species identifiers.
The human-specific genes identified in this RNA-seq dataset overlapped significantly with
the human-specific genes identified in the published microarray data (one-sided Fisher’s exact
test, p< 0.0001) [36]. To identify human-specific expression changes supported by the current
RNA-seq data as well as the published microarray data, we calculated the Pearson correlation
betweenRNA-seq and microarray expression curves. The correlations were calculated based
on expression levels of all three species interpolated at equal number of time points in each spe-
cies, as previously described [36,37], to ensure equal power across species. Specifically, for each
species, we interpolated expression values at 15 equally distributed points along the species’ age
range shared between RNA-seq and microarray data at the (age)1/4 scale. We used cubic spline
regression for interpolation, restricting the fit to three degrees of freedom.Human-specific
genes identified in RNA-seq or microarray datasets with Pearson correlation coefficient
betweenRNA-seq and microarray measurements greater than 0.5 were used as a consensus of
human-specific expression gene set in the following analysis.
Testing the Excess of Autism-AssociatedGenetic Mutations
To compare genes differentially expressed in autism with genes showing autism-associated
genetic mutations, we used the following data: (1) 791 genes in SFARI AutDB database, which
were extracted from studies on the molecular genetics and biology of ASD [38] (Updated in
December, 2015; https://gene.sfari.org/autdb/Welcome.do; S7 Fig); (2) 375 scored genes with
strong genetic evidence in the categories 1–4 in SFARI AutDB database (1 = high confidence,
2 = strong candidate, 3 = suggestive evidence, 4 = minimal evidence; Fig 2A); (3) 977 genes col-
lected from the AutismKB database, which were restricted to genes exacted from the genome-
wide association, linkage association, or low-scale association studies of autism spectrumdisor-
der (ASD) [39] (http://autismkb.cbi.pku.edu.cn/; S7 Fig); (4) 1500 genes with de novo muta-
tions associated with autism collected from four published whole-exome sequencing studies
[8,10–12]. To test the excess of overlap between genes differentially expressed in autism with
genes showing autism-associated genetic mutations, we calculated the expected-by-chance
overlap by randomly sampling the same number of genes expressed in PFC as within the tested
cluster, repeating the permutation 1,000 times.
To test the excess of autism-associatedmutations in the potential regulators identified in
cluster 2, we used the autism germlinemutation index of genes calculated by whole-genome
sequencing of monozygotic twins concordant for ASD and their parents from the study [50].
To calculate the significance of the excess of autism-related mutations in each gene, we com-
pared the mutation index within the tested genes with the ones of genes randomly selected
from the genome 1,000 times.
TF Binding Site EnrichmentAnalysis
The identification of putative TF binding sites (TFBSs) was conducted as previously described
[68]. Briefly, we identified the TFs showing enrichment of binding sites (TFBSs), in the regula-
tory region around the transcription start site of genes within one of the six clusters, and used
hypergeometric test p< 0.05 as nominal cutoff. We used genes in the other five clusters as
background.We further estimated the empirical significance of this result, and the randomly
expected number of TFs showing the same level of TFBS enrichment, by repeating analysis on
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1,000 random sets containing the same number of differentially expressed genes, sampled from
all genes differentially expressed between autism patients and unaffected controls. The putative
TFBSs were predicted using the Match algorithm [46] by scanning the TF consensus binding
sequences from the TRANSFAC database in the promoter regions of each human Ensembl
gene, defined as +/- 2 kb of the transcription start site (TSS). The predicted TFBSs were further
restricted to those with80% of nucleotides having defined phastCon score with the average
0.6 in the UCSC Genome Browser 17-way vertebrate ConservedElement table [69]. We thus
defined 156 TFBSs and 192 corresponding TFs (TFBS-TF mapping was done based on the
TRANSFAC binding site database). The correlated TFs and their potential targets were shown
in S5 Data.
TF-Target CorrelationAnalysis
We tested coexpression of TFs with enriched TFBS with their targets in the corresponding clus-
ter as described elsewhere [36,37,68]. Briefly, based on each TF with enriched targets within a
cluster, we calculated the Pearson’s correlation coefficients (PCCs) based on expression levels
of TF and its targets within a cluster, and compared them with PCCs based on expression levels
of TF and its targets in the other five clusters. We then compared the two PCC distributions
using the Mann-Whitney U (MWU) test. The correlated TFs were defined as having BH cor-
rectedMWU test p< 0.05 for tests based on expression levels in autism and in control samples.
To test whether positive correlations found betweenTFs and their predicted targets exceeded
expectation, the expected-by-chance numbers of correlated TFs were calculated by randomly
sampling the same number of autism differentially expressed genes within the tested cluster
and repeating the enrichment test 1,000 times.
In total, there were four TFs, EGR1–4, showing significant binding site enrichment in clus-
ter 2 genes, as well as significant expression profiles correlated with the expression of their pre-
dicted targets under p< 0.05 via BH correctedMWU test (Fig 4A). We have since tested the
authenticity of the EGR target predictions using data of EGR1–2 ChIP-seq peaks from the
ENCODE project [22] and two other studies [9,29]. We downloaded data from NCBI GEO,
where the ChIP-seq experiments were done in ECC-1, GM12878, H1-hESC, HCT-116, K562,
MCF-7, MAC, and LoVo cell lines (S6 Table). Data position coordinates of ChIP-seq peaks
were converted to hg19 genome builds using UCSC LiftOverwhen necessary. The annotate-
Peak function in the R package “ChIPseeker” was used to link peaks with the nearest gene and
genic region. For each ChIP-seq experiment, genes with peaks located within the promoter
regions (+/- 2 kb of the TSSs) were considered as potential targets of the TF. Fisher’s exact test
followed by BH correction for multiple testing was used to test the overlap of EGR targets pre-
dicted by searching TFBS sequencematrices from the TRANSFAC database in the promoter
regions using Match algorithm and the targets predicted by ChIP-Seq experiments (S14 Fig).
Supporting Information
S1 Data. Gene expression levels (RPKM values) for all expressed genes.Genes are shown in
rows. The sample group information (h: controls; a: autism cases; c: chimpanzees, m:
macaques) and age in days are shown in columns.
(TXT)
S2 Data. Dimensions 1 and 2 from themultidimensional scaling (MDS) of all expressed
genes in autism cases and unaffected controls.
(XLSX)
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S3 Data. Genes differently expressed between autism cases and unaffected controls. The
cluster information, gene ensemble ID, and gene HGNC ID are shown in the first to third col-
umns, respectively.
(TXT)
S4 Data. Observedand expectedgene numbers in Figs 2D, 3C and 4A. The expected num-
bers were estimated by 1,000 permutations of cluster labels.
(XLSX)
S5 Data. The correlated TFs and their potential targets.The cluster information, correlated
TFs, and their potential targets are shown in the first to third columns, respectively.
(TXT)
S1 Fig. Correlation of expression differences between autism and control groups measured
using RNA-seq and microarrays.The x-axis shows the mean expression difference between
autism and control cases in the RNA-seq dataset, and the y-axis, the microarray dataset. The
expression difference was calculated based on eight pairs of age-matched autism and control
samples measured in both datasets (S1 Table). Each point represents expression difference for
one gene; colors represent different gene sets (orange: genes with significant expression change
in autism identified by reanalyzing the published microarray data; purple: genes with signifi-
cant expression change in autism identified using the RNA-seq data; red: genes with significant
expression change in autism identified in both datasets; blue: all other genes detected in both
datasets). The inset numbers show the value of Pearson correlation coefficients for different
gene sets.
(PDF)
S2 Fig. The number and functional enrichment of clusters defined at different height cut-
offs of the hierarchical clustering tree. (A) Hierarchical clustering of 1,775 genes differently
expressed between autism cases and controls (the same as on Fig 2A). (B) Number of gene clus-
ters obtained by cutting the hierarchical clustering tree at different heights. Clusters containing
fewer than 40 genes were not counted. (C) The total number of GO functional terms and
KEGG pathways significantly overrepresented among genes in each of the clusters identified
using given tree cutting height cutoff. (D) Enrichment rank of GO functional terms and KEGG
pathways determined for each height cutoff. The ranks are based on the total number of signifi-
cantly enriched GO functional terms and KEGG pathways and were calculated using the rank
function in R.
(PDF)
S3 Fig. Gene clusters determinedusing log2-transformedRPKM values.The panels show
expression patterns of the seven gene clusters of autism-related genes identified using log2-
transformed RPKM values and uniform tree cutting cutoff at 1.4. The x-axis shows the age
information on the (age)1/4 scale, the y-axis shows the expression levels standardized to
mean = 0 and standard deviation = 1 before plotting. The points represent mean expression
levels in each individual (red: controls; black: autism cases); the lines show cubic spline curves
fitted to the individual data; the shaded areas show the standard deviation of the spline curves
within a cluster. The cluster number and the number of genes within the cluster are shown on
top of the panels.
(PDF)
S4 Fig. Comparison of clusters based on the original and log2-transformedvalues.The cells
show overlap between genes in six clusters used in the main analysis (x-axis) and genes in
seven clusters obtained using log2-transformedRPKM values and uniform tree cutting cutoff
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at 1.4 (y-axis). Each cell shows the number and percentage of overlapping genes; the p-value
indicating significance of the overlap calculated using Fisher's exact test followed by Benja-
mini-Hochberg (BH) correction for multiple testing.
(PDF)
S5 Fig. Comparison of clusters based on 1,775 genes differentially expressed in autism (x-
axis) and all 12,557 detected genes. The cells show overlap between genes in six clusters used
in main analysis (x-axis) and genes in 48 clusters based on analysis of all 12,557 detected genes
using RPKM values and uniform tree cutting cutoff at 1.4 (y-axis). Each cell shows the number
and percentage of overlapping genes; the p-value indicating significance of the overlap calcu-
lated using Fisher’s exact test followed by Benjamini-Hochberg (BH) correction for multiple
testing. The 48 clusters shown on the y-axis were sorted based on their BH-corrected p-values
from the Fisher's exact test.
(PDF)
S6 Fig. EnrichedGO functional terms of cluster 4 (Call_4), overlapping with cluster 2 of
themain analysis.GO functional terms significantly enriched in cluster 4 (Call_4) genes
defined based on clustering of all genes detected as expressed in autism and control samples.
The enriched functional terms (y-axis) were sorted based on the hypergeometric test p-values
corrected for multiple testing using Benjamini-Hochberg (BH) correction. The x-axis shows–
log10-transformated adjusted p-values of the enrichment test.
(PDF)
S7 Fig. Profiles of expression changes in autism drawn for different levels of the disease
phenotype.The symbols represent individual expression level measurements (red circles: con-
trols; black stars: autism cases with high ADI-R scores; black triangles: autism cases with mod-
erate ADI-R scores; black crosses: autism cases with low ADI-R scores). The lines represent
cubic spline curves fitted to individual’s data (red: fitted to controls; gray: fitted to all autism
cases; black: fitted to autism cases with moderate ADI-R scores). The x-axis shows age informa-
tion and the y-axis shows the expression levels. Expression levels of all genes were standardized
to mean = 0 and standard deviation = 1 before plotting. The titles on top of each panel show
cluster information and the number of genes in each cluster.
(PDF)
S8 Fig. Overlap between genes from six clusters representingmajor patterns of autism-
related expression changes and genes associatedwith autism. The genes associated with
autism were collected from: (A) the SFARI AutDB database, (B) the AutismKB database, (C)
four published whole-exome sequencing studies. In each panel, the red bars show the actual
numbers of overlapping genes, and the streaked bars show the mean number of overlapping
genes expected by chance, estimated by 1,000 permutations of cluster labels. The symbols
above the bars show the significance of the overlap, based on 1,000 permutations of cluster
labels (: p< 0.001; : p< 0.05).
(PDF)
S9 Fig. Gene length distribution in six major clusters of expression changes in autism. (A)
The distribution for all genes in each cluster. (B) The distribution for genes sampled based on
cluster 2 gene length distribution.
(PDF)
S10 Fig. Overlap between genes associatedwith autism based on genetic studies and genes
in six major clusters of expression changes in autism corrected for length difference as
shown in S9 Fig. The genes associated with autism were collected from: (A) the SFARI AutDB
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database, (B) the SFARI scored genes, (C) the AutismKB database, (D) four published whole-
exome sequencing studies. In each panel, the red bars show the actual numbers of overlapping
genes, and the streaked bars show the mean number of overlapping genes expected by chance,
estimated by 1,000 permutations of cluster labels. The symbols above the bars show the signifi-
cance of the overlap, based on 1,000 permutations of cluster labels (: p< 0.001; : p< 0.01;
: p< 0.05).
(PDF)
S11 Fig. Overlap of autism-related clusters (x-axis) and cell typemarkers collected from
Zeisel et al, 2015 (y-axis). Each cell shows the number and percentage of overlapping genes;
the p-value indicating significance of the overlap calculated using Fisher’s exact test followed
by BH correction for multiple testing. The y-axis marker colors represent cell types (purple:
neuron; orange: glia; blue: others).
(PDF)
S12 Fig. Overlap between genes highly expressed in neurons and the six major clusters of
expression changes in autism. The y-axis shows relative numbers of overlapping genes calcu-
lated as the log2 ratio between the observedgene number and the number expected by chance,
calculated by 1,000 permutations of cluster labels. The error bars show the standard deviation
of the fold-change estimates. The symbols above the bars show the significance of the overlap
based on the 1,000 permutations (: p< 0.001; : p< 0.01; o: p< 0.1). Genes in cluster 5 are
enriched in the marker genes of CCK-responsive (CCK+) neurons collected from Cahoy et al,
2008 (S3 Table).
(PDF)
S13 Fig. Overlap of autism-related clusters (x-axis) and marker genes located in subcellular
structures of neurons (y-axis).Marker genes located in presynapse, postsynapse, synaptic ves-
icle, axon, and dendrite collected based on GO cellular component annotation. Marker genes
located in remaining neuron locations (category “Neuron” in the y-axis) were identified by
excluding synapse, axon, and dendrite-related genes from neuron-related genes classified
according to GO cellular component annotation. Each cell shows the number and percentage
of overlapping genes; the p-value indicating significance of the overlap calculated using Fisher’s
exact test followed by BH correction for multiple testing.
(PDF)
S14 Fig. Overlap between six clusters used in the original analysis (x-axis) andmacaque
cortical layer marker genes for layers 2–5 (y-axis) collected from Bernard et al, 2012. Each
cell shows the number and percentage of overlapping genes; the p-value indicating significance
of the overlap calculated using Fisher's exact test followed by BH correction for multiple test-
ing.
(PDF)
S15 Fig. Correlation of age-related gene expression change betweenRNA-seq and microar-
ray datasets. Shown are the distributions of Pearson correlation coefficients calculated based
on expression levels at 15 points interpolated from the cubic spline curves fitted to individual
microarray or RNA-seq expression measurements of each species (red: humans, blue: chim-
panzees, green: macaque monkeys) or based on the expression levels interpolated using data
from all three species (gray line). The distributions are based on 1,428 genes with human-spe-
cific developmental expression profiles in the PFC identified using microarray or RNA-seq
data.
(PDF)
Disruptionof an Evolutionarily Novel Synaptic Expression Pattern in Autism
PLOS Biology | DOI:10.1371/journal.pbio.1002558 September 29, 2016 17 / 23
S16 Fig. Expression profiles of pre- and postsynapticmarker genes, SYP and DLG4, in pri-
mate PFC. The boxes show median expression and the inter-quartile expression variation of
SYP and DLG4 measured using RNA-seq. Colors represent different species (red: humans,
blue: chimpanzees, green:macaque monkeys). To reduce inter-individual variation, individuals
with similar ages were combined in seven age groups shown by dashed gray lines with age
range indicated below (m: months, y: years).
(PDF)
S17 Fig. Expression profiles of synapse-relatedgenes measured by RNA-seq (left panel)
or microarrays (right panel). The x-axis shows the age information on the (age)1/4 scale,
the y-axis shows the expression levels standardized to mean = 0 and standard deviation = 1
before plotting. The points represent mean expression levels in each individual (red: con-
trols; black: autism cases; blue: chimpanzees, green: macaques), the lines show cubic spline
curves fitted to the individual data, and the error bars show standard deviation of the spline
curves.
(PDF)
S18 Fig. Distribution of Pearson correlation coefficientsbetween gene expression and
H3K4me3modificationdifferences in autism and control individuals.The expression dif-
ference or modification difference was calculated based on 8 pairs of age-matched autism and
control samples in both datasets (S1 Table), with age ranged from 2 to 60 years old. The red
lines represent the correlation coefficient distribution of genes in each cluster. The gray lines
represent background distributions from other expressed genes. The cluster number and the
significance of the positive correlation excess based on one-sided Wilcoxon test are shown on
top of the cluster panels (: p< 0.001; : p< 0.01).
(PDF)
S19 Fig. Comparison of computationally predicted and ChIP-seq-basedEGR1/2 target
genes.Cells show overlap of EGR1/2 target genes predicted using the TRANSFAC-based
Match algorithm (“predict”) and identified using ChIP-seq data (S6 Table). Each cell shows the
number and percentage of overlapping genes; the p-value indicating significance of the overlap
calculated using Fisher's exact test followed by BH correction for multiple testing.
(PDF)
S20 Fig. Distribution of mutations determinedby the DNA sequence comparison between
10 monozygotic twins diagnosedwith autism and their non-affected siblings. The red
arrow indicates the mutation index in the four TF genes (EGR1-4) identified as potential regu-
lators of the expression pattern detected in autism represented by the cluster 2. Note that EGR1
is enriched in mutations linked with autism (permutation test, p< 0.05 for EGR1).
(PDF)
S1 Table. Sample information.
(PDF)
S2 Table. Summary of sequence reads in the RNA-seq batch.
(PDF)
S3 Table. Functional characteristicsof genes in autism differentially expressed patterns.
(PDF)
S4 Table. Clinical information of autistic individuals used in this study.
(PDF)
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S5 Table. Functional characteristicsof overlapped genes between human-specificgenes and
autistic differentially expressed genes.
(PDF)





We thank the NICHD Brain and Tissue Bank for Developmental Disorders, the Harvard Brain
Tissue Resource Center, and the Maryland Brain CollectionCenter for providing the unaf-
fected and autistic human samples; the National Chimpanzee Brain Resource (supported by
NINDS grant NS092988), the Biomedical Primate Research Centre, the Burgers’ Zoo in Arn-
hem, the Southwest National Primate Research Center, Alamogordo Primate Facility, and Dr.
R. Martin and Dr. W. Scheffran for providing the chimpanzee samples; Suzhou Drug Safety
Evaluation and Research Center and C. Lian, H. Cai, and X. Zheng for providing the macaque
samples. We thank Dr. Jane Pickett and Carolyn Komich Hare from the Autism Tissue Pro-
gram of Autism Speaks for providing the clinical records for the autistic samples, Dr. M. Lach-
mann for critical advice, and Dr. J. Boyd-Kirkup and Dr. G. L. Banes for their helpful
comments on the manuscript.
Author Contributions
Conceptualization:XL SP SA PK.
Formal analysis:XL DH MS HH.
Funding acquisition:XL DH PK.
Investigation: DH XJ PG NZ.
Methodology:XL DH MS.
Project administration:XL PK.
Resources:AM TH JJE CCS PRH ZQ.
Supervision:XL PK.
Validation: XL DH MS.
Visualization: XL DH MS.
Writing – original draft:XL DH MS PK.
Writing – review& editing: SP SA.
References
1. Kanner L. Autistic Disturbances of Affective Contact. NervousChild 1943; 2:217–50.
2. Rogers SJ, DiLalla DL. Age of symptom onset in young childrenwith pervasive developmental disor-
ders. J AmAcad Child Adolesc Psychiatry. 1990; 29(6):863–72. PMID: 2273012.
3. Lord C, Risi S. Diagnosis of Autism SpectrumDisorders in Young Children. In: Autism SpectrumDisor-
ders: A Transactional Developmental Perspective. Wetherby AM, Prizant BM, editors. Baltimore: Paul
H. Brookes Publishing Co.; 2000.
Disruptionof an Evolutionarily Novel Synaptic Expression Pattern in Autism
PLOS Biology | DOI:10.1371/journal.pbio.1002558 September 29, 2016 19 / 23
4. Lai MC, LombardoMV, Baron-Cohen S. Autism. Lancet. 2014; 383(9920):896–910. doi: 10.1016/
S0140-6736(13)61539-1 PMID: 24074734.
5. Hansen SN, Schendel DE, Parner ET. Explaining the increase in the prevalence of autism spectrum
disorders: the proportionattributable to changes in reportingpractices. JAMA pediatrics. 2015; 169
(1):56–62. doi: 10.1001/jamapediatrics.2014.1893PMID: 25365033.
6. Developmental Disabilities MonitoringNetworkSurveillance Year Principal I, Centers for Disease C,
Prevention. Prevalence of autism spectrumdisorder among children aged 8 years—autism and devel-
opmental disabilitiesmonitoringnetwork, 11 sites, United States, 2010. Morbidity andmortalityweekly
reportSurveillance summaries. 2014; 63(2):1–21.PMID: 24670961.
7. Russell G, Rodgers LR, Ukoumunne OC, Ford T. Prevalence of parent-reportedASD and ADHD in the
UK: findings from theMillenniumCohortStudy. J Autism Dev Disord. 2014; 44(1):31–40. doi: 10.1007/
s10803-013-1849-0PMID: 23719853.
8. Rumsey JM, Hamburger SD. Neuropsychological findings in high-functioningmenwith infantile autism,
residual state. Journal of clinical and experimental neuropsychology. 1988; 10(2):201–21. doi: 10.
1080/01688638808408236 PMID: 3350920.
9. Walsh CA, Morrow EM, Rubenstein JL. Autism and brain development. Cell. 2008; 135(3):396–400.
doi: 10.1016/j.cell.2008.10.015PMID: 18984148; PubMed Central PMCID: PMC2701104.
10. BelmonteMK, Allen G, Beckel-Mitchener A, Boulanger LM, CarperRA,Webb SJ. Autism and abnormal
development of brain connectivity. J Neurosci. 2004; 24(42):9228–31. doi: 10.1523/JNEUROSCI.
3340-04.2004 PMID: 15496656.
11. CourchesneE, KarnsCM, Davis HR, Ziccardi R, CarperRA, Tigue ZD, et al. Unusual brain growth pat-
terns in early life in patients with autistic disorder:an MRI study. Neurology. 2001; 57(2):245–54. PMID:
11468308.
12. SchumannCM, Hamstra J, Goodlin-Jones BL, Lotspeich LJ, Kwon H, BuonocoreMH, et al. The amyg-
dala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J
Neurosci. 2004; 24(28):6392–401. doi: 10.1523/JNEUROSCI.1297-04.2004 PMID: 15254095.
13. Wolff JJ, Gu H, GerigG, Elison JT, StynerM, GouttardS, et al. Differences in whitematter fiber tract
development present from 6 to 24months in infants with autism. Am J Psychiatry. 2012; 169(6):589–
600. doi: 10.1176/appi.ajp.2011.11091447PMID: 22362397; PubMedCentral PMCID: PMC3377782.
14. CourchesneE, Mouton PR, CalhounME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, et al. Neuron
number and size in prefrontal cortex of childrenwith autism. JAMA. 2011; 306(18):2001–10. doi: 10.
1001/jama.2011.1638PMID: 22068992.
15. Tang G, Gudsnuk K, Kuo SH, CotrinaML, Rosoklija G, Sosunov A, et al. Loss of mTOR-dependent
macroautophagy causes autistic-like synaptic pruningdeficits. Neuron. 2014; 83(5):1131–43. doi: 10.
1016/j.neuron.2014.07.040 PMID: 25155956; PubMedCentral PMCID: PMC4159743.
16. Hutsler JJ, ZhangH. Increased dendritic spine densities on cortical projection neurons in autism spec-
trumdisorders. Brain Res. 2010; 1309:83–94. doi: 10.1016/j.brainres.2009.09.120PMID: 19896929.
17. Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature.Mol
Psychiatry. 2007; 12(1):2–22. doi: 10.1038/sj.mp.4001896PMID: 17033636.
18. Gaugler T, Klei L, Sanders SJ, Bodea CA, GoldbergAP, Lee AB, et al. Most genetic risk for autism
resides with common variation. Nat Genet. 2014; 46(8):881–5. doi: 10.1038/ng.3039 PMID: 25038753;
PubMedCentral PMCID: PMC4137411.
19. GeschwindDH. Genetics of autism spectrumdisorders. Trends in cognitive sciences. 2011; 15
(9):409–16.doi: 10.1016/j.tics.2011.07.003 PMID: 21855394; PubMedCentral PMCID: PMC3691066.
20. Murdoch JD, StateMW. Recent developments in the genetics of autism spectrumdisorders. Curr Opin
Genet Dev. 2013; 23(3):310–5. doi: 10.1016/j.gde.2013.02.003PMID: 23537858.
21. StateMW, Levitt P. The conundrumsof understanding genetic risks for autism spectrumdisorders. Nat
Neurosci. 2011; 14(12):1499–506. doi: 10.1038/nn.2924 PMID: 22037497; PubMedCentral PMCID:
PMC3940335.
22. Sanders SJ, He X, Willsey AJ, Ercan-Sencicek AG, Samocha KE, Cicek AE, et al. Insights into Autism
SpectrumDisorder Genomic Architecture and Biology from 71 Risk Loci. Neuron. 2015; 87(6):1215–
33. doi: 10.1016/j.neuron.2015.09.016PMID: 26402605; PubMedCentral PMCID: PMC4624267.
23. Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, et al. Coexpression networks impli-
cate humanmidfetal deep cortical projection neurons in the pathogenesis of autism. Cell. 2013; 155
(5):997–1007. doi: 10.1016/j.cell.2013.10.020PMID: 24267886; PubMed Central PMCID:
PMC3995413.
24. Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, Chandran V, et al. Integrative functional genomic
analyses implicate specific molecular pathways and circuits in autism.Cell. 2013; 155(5):1008–21. doi:
10.1016/j.cell.2013.10.031 PMID: 24267887; PubMedCentral PMCID: PMC3934107.
Disruptionof an Evolutionarily Novel Synaptic Expression Pattern in Autism
PLOS Biology | DOI:10.1371/journal.pbio.1002558 September 29, 2016 20 / 23
25. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, et al. Transcriptomic analysis of autistic
brain reveals convergent molecular pathology. Nature. 2011; 474(7351):380–4. doi: 10.1038/
nature10110 PMID: 21614001.
26. Garbett K, EbertPJ, Mitchell A, Lintas C, Manzi B, MirnicsK, et al. Immune transcriptome alterations in
the temporal cortex of subjects with autism. Neurobiol Dis. 2008; 30(3):303–11. doi: 10.1016/j.nbd.
2008.01.012PMID: 18378158; PubMed Central PMCID: PMC2693090.
27. ChowML, Pramparo T, WinnME, BarnesCC, Li HR,Weiss L, et al. Age-dependent brain gene expres-
sion and copy number anomalies in autism suggest distinct pathological processes at young versus
mature ages. PLoSGenet. 2012; 8(3):e1002592. PMID: 22457638. doi: 10.1371/journal.pgen.
1002592
28. Gupta S, Ellis SE, Ashar FN, Moes A, Bader JS, Zhan J, et al. Transcriptome analysis reveals dysregu-
lation of innate immune response genes and neuronal activity-dependent genes in autism.Nature com-
munications. 2014; 5:5748. doi: 10.1038/ncomms6748PMID: 25494366; PubMedCentral PMCID:
PMC4270294.
29. Liu Z, Li X, Zhang JT, Cai YJ, Cheng TL, Cheng C, et al. Autism-like behaviours and germline transmis-
sion in transgenicmonkeys overexpressing MeCP2. Nature. 2016; 530(7588):98–102. doi: 10.1038/
nature16533 PMID: 26808898.
30. Tomasello M, CarpenterM, Call J, Behne T, Moll H. Understanding and sharing intentions: the origins
of cultural cognition. Behav Brain Sci. 2005; 28(5):675–91; discussion 91–735. doi: 10.1017/
S0140525X05000129PMID: 16262930.
31. Hill K, BartonM, HurtadoAM. The emergenceof human uniqueness: Characters underlyingbehavioral
modernity. Evol Anthropol. 2009; 18(5):187–200.
32. Whiten A, Erdal D. The human socio-cognitive niche and its evolutionary origins. Philos Trans R Soc
Lond, B, Biol Sci. 2012; 367(1599):2119–29. doi: 10.1098/rstb.2012.0114 PMID: 22734055.
33. Tennie C, Call J, Tomasello M. Ratcheting up the ratchet: on the evolution of cumulative culture. Philos
Trans R Soc Lond, B, Biol Sci. 2009; 364(1528):2405–15. doi: 10.1098/rstb.2009.0052 PMID:
19620111.
34. Boyd R, RichersonPJ, Henrich J. The cultural niche: why social learning is essential for human adapta-
tion. Proc Natl Acad Sci U S A. 2011; 108 Suppl 2:10918–25. doi: 10.1073/pnas.1100290108 PMID:
21690340; PubMed Central PMCID: PMC3131818.
35. HerrmannE, Call J, Hernandez-LloredaMV, Hare B, Tomasello M. Humans have evolved specialized
skills of social cognition: the cultural intelligence hypothesis. Science. 2007; 317(5843):1360–6. doi:
10.1126/science.1146282 PMID: 17823346.
36. Liu X, Somel M, Tang L, Yan Z, Jiang X, Guo S, et al. Extension of cortical synaptic development distin-
guishes humans from chimpanzees andmacaques. GenomeRes. 2012; 22:611–22. doi: 10.1101/gr.
127324.111PMID: 22300767.
37. Somel M, Liu X, Tang L, Yan Z, Hu H, Guo S, et al. MicroRNA-Driven Developmental Remodeling in
the Brain Distinguishes Humans fromOther Primates. PLoS Biol. 2011; 9(12):e1001214. doi: 10.1371/
journal.pbio.1001214 PMID: 22162950.
38. Basu SN, Kollu R, Banerjee-Basu S. AutDB: a gene reference resource for autism research.Nucleic
Acids Res. 2009; 37(Database issue):D832–6. PMID: 19015121. doi: 10.1093/nar/gkn835
39. Xu LM, Li JR, Huang Y, ZhaoM, Tang X, Wei L. AutismKB: an evidence-based knowledgebase of
autism genetics. Nucleic Acids Res. 2012; 40(Database issue):D1016–22. PMID: 22139918. doi: 10.
1093/nar/gkr1145
40. Cahoy JD, EmeryB, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, et al. A transcriptome data-
base for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain develop-
ment and function. J Neurosci. 2008; 28(1):264–78. doi: 10.1523/JNEUROSCI.4178-07.2008 PMID:
18171944.
41. Rakic P, Bourgeois JP, Eckenhoff MF, Zecevic N, Goldman-Rakic PS. Concurrent overproduction of
synapses in diverse regions of the primate cerebral cortex. Science. 1986; 232(4747):232–5. PMID:
3952506.
42. HuttenlocherPR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J
CompNeurol. 1997; 387(2):167–78. PMID: 9336221.
43. Glantz LA, Gilmore JH, HamerRM, LiebermanJA, Jarskog LF. Synaptophysin and postsynaptic den-
sity protein 95 in the human prefrontal cortex frommid-gestation into early adulthood.Neuroscience.
2007; 149(3):582–91. doi: 10.1016/j.neuroscience.2007.06.036PMID: 17916412.
44. Thompson-Schill SL, RamscarM, ChrysikouEG. Cognition without control:When a little frontal lobe
goes a long way. Current directions in psychological science. 2009; 18(5):259–63. doi: 10.1111/j.1467-
8721.2009.01648.x PMID: 20401341; PubMedCentral PMCID: PMC2855545.
Disruptionof an Evolutionarily Novel Synaptic Expression Pattern in Autism
PLOS Biology | DOI:10.1371/journal.pbio.1002558 September 29, 2016 21 / 23
45. Shulha HP, Cheung I, Whittle C, Wang J, Virgil D, Lin CL, et al. Epigenetic signatures of autism: tri-
methylated H3K4 landscapes in prefrontal neurons. Arch Gen Psychiatry. 2011; 69(3):314–24. PMID:
22065254. doi: 10.1001/archgenpsychiatry.2011.151
46. Kel AE, Gössling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, WingenderE. MATCH: A tool for
searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 2003; 31(13):3576–
9. PMID: 12824369.
47. Li L, Yun SH, Keblesh J, Trommer BL, Xiong H, Radulovic J, et al. Egr3, a synaptic activity regulated
transcription factor that is essential for learningandmemory. Mol Cell Neurosci. 2007; 35(1):76–88.
doi: 10.1016/j.mcn.2007.02.004 PMID: 17350282.
48. Knapska E, Kaczmarek L. A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/
Krox-24/TIS8/ZENK? Progress in neurobiology. 2004; 74(4):183–211. doi: 10.1016/j.pneurobio.2004.
05.007 PMID: 15556287.
49. BartholomaP, ErlandssonN, KaufmannK, Rossler OG, BaumannB, WirthT, et al. Neuronal cell death
induced by antidepressants: lack of correlationwith Egr-1, NF-kappaB and extracellular signal-regu-
lated protein kinase activation. BiochemPharmacol. 2002; 63(8):1507–16. PMID: 11996893.
50. Michaelson JJ, Shi Y, Gujral M, ZhengH, MalhotraD, Jin X, et al. Whole-genome sequencing in autism
identifies hot spots for de novo germlinemutation. Cell. 2012; 151(7):1431–42.
51. CourchesneE, CarperR, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism.
Jama. 2003; 290(3):337–44. PMID: 12865374.
52. Dawson G, Munson J, Webb SJ, Nalty T, Abbott R, Toth K. Rate of head growth decelerates and symp-
tomsworsen in the second year of life in autism. Biol Psychiatry. 2007; 61(4):458–64. PMID:
17137564.
53. Dissanayake C, Bui QM, Huggins R, Loesch DZ. Growth in stature and head circumference in high-
functioning autism and Asperger disorder during the first 3 years of life. Dev Psychopathol. 2006; 18
(2):381–93.PMID: 16600060.
54. BelmonteMK, Cook EH Jr., AndersonGM, Rubenstein JL, GreenoughWT, Beckel-Mitchener A, et al.
Autism as a disorder of neural information processing: directions for research and targets for therapy.
Mol Psychiatry. 2004; 9(7):646–63. PMID: 15037868.
55. Brock J, Brown CC, Boucher J, RipponG. The temporal binding deficit hypothesis of autism. Dev Psy-
chopathol. 2002; 14(2):209–24. PMID: 12030688.
56. Just MA, CherkasskyVL, Keller TA, MinshewNJ. Corticalactivation and synchronization during sen-
tence comprehension in high-functioning autism: evidence of underconnectivity. Brain. 2004; 127(Pt
8):1811–21. PMID: 15215213.
57. Rubenstein JL, Merzenich MM.Model of autism: increased ratio of excitation/inhibition in key neural
systems. Genes Brain Behav. 2003; 2(5):255–67.PMID: 14606691.
58. Chiocchetti AG, Kopp M,Waltes R, Haslinger D, Duketis E, Jarczok TA, et al. Variants of the CNTNAP2
5' promoter as risk factors for autism spectrumdisorders: a genetic and functional approach.Mol Psy-
chiatry. 2015; 20(7):839–49.
59. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by
mutations in X-linkedMECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999; 23(2):185–8.
doi: 10.1038/13810 PMID: 10508514.
60. Swanberg SE, Nagarajan RP, Peddada S, Yasui DH, LaSalle JM. Reciprocal co-regulation of EGR2
andMECP2 is disrupted in Rett syndromeand autism. HumMol Genet. 2009; 18(3):525–34. doi: 10.
1093/hmg/ddn380 PMID: 19000991; PubMedCentral PMCID: PMC2638799.
61. Hu VW, Frank BC, Heine S, Lee NH, Quackenbush J. Gene expression profiling of lymphoblastoid cell
lines frommonozygotic twins discordant in severity of autism reveals differential regulation of neurologi-
cally relevant genes. BMCGenomics. 2006; 7:118. doi: 10.1186/1471-2164-7-118 PMID: 16709250;
PubMedCentral PMCID: PMC1525191.
62. Davis S, Bozon B, LarocheS. How necessary is the activation of the immediate early gene zif268 in
synaptic plasticity and learning?Behav Brain Res. 2003; 142(1–2):17–30. PMID: 12798262.
63. Mo J, KimCH, Lee D, SunW, Lee HW, Kim H. Early growth response 1 (Egr-1) directly regulates
GABAA receptor alpha2, alpha4, and theta subunits in the hippocampus. J Neurochem. 2015; 133
(4):489–500. doi: 10.1111/jnc.13077 PMID: 25708312.
64. Baron-Cohen S, Ashwin E, Ashwin C, Tavassoli T, Chakrabarti B. Talent in autism: hyper-systemizing,
hyper-attention to detail and sensoryhypersensitivity. Philos Trans R Soc Lond B Biol Sci. 2009; 364
(1522):1377–83. doi: 10.1098/rstb.2008.0337PMID: 19528020; PubMedCentral PMCID:PMC2677592.
65. LangmeadB, Trapnell C, Pop M, Salzberg SL. Ultrafast andmemory-efficient alignment of shortDNA
sequences to the human genome. GenomeBiol. 2009; 10(3):R25. PMID: 19261174. doi: 10.1186/gb-
2009-10-3-r25
Disruptionof an Evolutionarily Novel Synaptic Expression Pattern in Autism
PLOS Biology | DOI:10.1371/journal.pbio.1002558 September 29, 2016 22 / 23
66. Faraway J. Practical Regression and Anova Using R. 2002. http://cran.r-project.org/doc/contrib/
Faraway-PRA.pdf.
67. Somel M, Franz H, Yan Z, Lorenc A, Guo S, Giger T, et al. Transcriptional neoteny in the human brain.
Proc Natl Acad Sci U S A. 2009; 106(14):5743–8. Epub 2009/03/25. doi: 10.1073/pnas.0900544106
PMID: 19307592; PubMedCentral PMCID: PMC2659716.
68. Somel M, Guo S, Fu N, Yan Z, Hu HY, Xu Y, et al. MicroRNA,mRNA, and protein expression link devel-
opment and aging in human andmacaque brain. GenomeRes. 2010; 20:1207–18. doi: 10.1101/gr.
106849.110PMID: 20647238.
69. Siepel A, Bejerano G, Pedersen JS, HinrichsAS, HouM, RosenbloomK, et al. Evolutionarily conserved
elements in vertebrate, insect, worm, and yeast genomes. GenomeRes. 2005; 15(8):1034–50. doi: 10.
1101/gr.3715005 PMID: 16024819.
Disruptionof an Evolutionarily Novel Synaptic Expression Pattern in Autism
PLOS Biology | DOI:10.1371/journal.pbio.1002558 September 29, 2016 23 / 23
